Physiomics (PYC) Competitors GBX 0.70 -0.05 (-6.67%) (As of 12/20/2024 11:42 AM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlines PYC vs. FAB, ROQ, IXI, GENF, IMM, EVG, OBD, MTFB, DEST, and BSFAShould you be buying Physiomics stock or one of its competitors? The main competitors of Physiomics include Fusion Antibodies (FAB), Roquefort Therapeutics (ROQ), IXICO (IXI), Genflow Biosciences (GENF), ImmuPharma (IMM), Evgen Pharma (EVG), Oxford BioDynamics (OBD), Motif Bio (MTFB), Destiny Pharma (DEST), and BSF Enterprise (BSFA). These companies are all part of the "biotechnology" industry. Physiomics vs. Fusion Antibodies Roquefort Therapeutics IXICO Genflow Biosciences ImmuPharma Evgen Pharma Oxford BioDynamics Motif Bio Destiny Pharma BSF Enterprise Physiomics (LON:PYC) and Fusion Antibodies (LON:FAB) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, institutional ownership, profitability, dividends, analyst recommendations, community ranking, media sentiment and valuation. Does the MarketBeat Community prefer PYC or FAB? Physiomics received 26 more outperform votes than Fusion Antibodies when rated by MarketBeat users. However, 68.35% of users gave Fusion Antibodies an outperform vote while only 55.56% of users gave Physiomics an outperform vote. CompanyUnderperformOutperformPhysiomicsOutperform Votes8055.56% Underperform Votes6444.44% Fusion AntibodiesOutperform Votes5468.35% Underperform Votes2531.65% Do insiders & institutionals have more ownership in PYC or FAB? 21.0% of Fusion Antibodies shares are owned by institutional investors. 4.2% of Physiomics shares are owned by company insiders. Comparatively, 11.4% of Fusion Antibodies shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Does the media favor PYC or FAB? In the previous week, Physiomics' average media sentiment score of 0.00 equaled Fusion Antibodies'average media sentiment score. Company Overall Sentiment Physiomics Neutral Fusion Antibodies Neutral Is PYC or FAB more profitable? Physiomics has a net margin of -106.80% compared to Fusion Antibodies' net margin of -195.95%. Physiomics' return on equity of -149.67% beat Fusion Antibodies' return on equity.Company Net Margins Return on Equity Return on Assets Physiomics-106.80% -149.67% -76.38% Fusion Antibodies -195.95%-152.68%-63.78% Which has more risk and volatility, PYC or FAB? Physiomics has a beta of 1.69, indicating that its stock price is 69% more volatile than the S&P 500. Comparatively, Fusion Antibodies has a beta of 0.49, indicating that its stock price is 51% less volatile than the S&P 500. Which has preferable earnings and valuation, PYC or FAB? Physiomics has higher earnings, but lower revenue than Fusion Antibodies. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPhysiomics£900.71K1.58N/AN/AN/AFusion Antibodies£1.14M5.76-£2.19M-£0.04-172.28 SummaryFusion Antibodies beats Physiomics on 6 of the 11 factors compared between the two stocks. Ad Wealthpin ProVacuum up cash with these special trades? Have you ever heard about a “volatility vacuum?” Most people haven’t. It all revolves around this formula right here. Now, the most important thing is that this equation — when applied to certain tickers at a certain time each month —- can trigger these “volatility vacuums.” And when that happens, anyone has the shot at sucking out payouts of $290, $350, even $1,350 in as little as 24 hours. (With just a $1k starting stake!) Granted, there were smaller wins and those that did not work out but best of all, we can know exactly when these opportunities will hit. I’ve used this info to create a Cash Calendar that lays out the precise dates of these payouts. And I’m sending it for FREE to anyone who joins me during my FREE training right here. Get Physiomics News Delivered to You Automatically Sign up to receive the latest news and ratings for PYC and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PYC vs. The Competition Export to ExcelMetricPhysiomicsBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£1.42M£165.68M£5.14B£1.92BDividend Yield6.20%3.64%5.09%5.45%P/E Ratio-13.83115.5189.971,880.82Price / Sales1.5818,531.021,116.34397,035.90Price / Cash4.2112.8743.1028.78Price / BookN/A8.594.782.81Net IncomeN/A-£20.67M£120.31M£156.11M7 Day Performance-12.50%-1.05%-1.92%-2.03%1 Month Performance1.16%174.77%13.65%21.85%1 Year Performance-54.66%134.18%28.34%30.10% Physiomics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PYCPhysiomicsN/AGBX 0.70-6.7%N/A-54.2%£1.42M£900,707.00-13.8310Gap UpFABFusion AntibodiesN/AGBX 6.70+1.5%N/A+53.1%£6.39M£1.14M-167.4048High Trading VolumeROQRoquefort TherapeuticsN/AGBX 4.50flatN/A-45.9%£5.81M£637.00-467.509IXIIXICON/AGBX 11.50flatN/A-13.6%£5.56M£6M-278.7589GENFGenflow BiosciencesN/AGBX 1.45-9.2%N/A+7.1%£5.08MN/A-154.005Gap DownHigh Trading VolumeIMMImmuPharmaN/AGBX 1.05-13.3%N/A-26.6%£4.36M£94,819.00-115.0013Gap DownEVGEvgen PharmaN/AN/AN/AN/A£3.42MN/A-80.0010OBDOxford BioDynamicsN/AGBX 1.06-12.4%N/A-95.9%£3.29M£176,000.00-17.5845News CoverageGap DownHigh Trading VolumeMTFBMotif BioN/AGBX 0.50flatN/AN/A£3.28MN/A-0.036DESTDestiny PharmaN/AGBX 3-30.1%N/A-95.8%£2.87M£135,028.00-50.0024Gap DownHigh Trading VolumeBSFABSF EnterpriseN/AGBX 2.38flatN/A-75.0%£2.45MN/A-113.2512 Related Companies and Tools Related Companies Fusion Antibodies Competitors Roquefort Therapeutics Competitors IXICO Competitors Genflow Biosciences Competitors ImmuPharma Competitors Evgen Pharma Competitors Oxford BioDynamics Competitors Motif Bio Competitors Destiny Pharma Competitors BSF Enterprise Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:PYC) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredTech funds are hemorrhaging cash: Sell this stock nowSomething very strange is happening to U.S. stocks following President Trump's victory... And this could s...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Physiomics Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Physiomics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
